MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

MC

471.05

-0.04%↓

SANES

7.059

+0.26%↑

BNP

78.09

+1.13%↑

ALV

354.5

+0.25%↑

MUV2

575.8

+0.07%↑

Search

Sartorius Stedim Biotech.

Затворен

СекторФинансови

193.3 -0.1

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

188.55

Максимум

195.2

Ключови измерители

By Trading Economics

Приходи

75M

115M

Продажби

-6.7M

745M

P/E

Средно за сектора

89.81

24.968

EPS

1.16

Дивидентна доходност

0.36

Марж на печалбата

15.498

Служители

9,961

EBITDA

124M

256M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+21.06% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.36%

4.18%

Следващи печалби

22.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

2.3B

19B

Предишно отваряне

193.4

Предишно затваряне

193.3

Настроения в новините

By Acuity

13%

87%

14 / 538 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Sartorius Stedim Biotech. Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.06.2025 г., 20:45 ч. UTC

Печалби

Broadcom 2Q Sales Climb on Booming AI Demand

5.06.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5.06.2025 г., 23:44 ч. UTC

Пазарно говорене

Gold Edges Higher on Weak U.S. Data -- Market Talk

5.06.2025 г., 23:30 ч. UTC

Пазарно говорене

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5.06.2025 г., 21:32 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

5.06.2025 г., 20:45 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:24 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Rev $15B >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Net $4.97B >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Adj EPS $1.58 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q EPS $1.03 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom Sees 3Q Rev $15.8B >AVGO

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5.06.2025 г., 19:22 ч. UTC

Пазарно говорене

Oil Futures Resume Upward Moves -- Market Talk

5.06.2025 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5.06.2025 г., 18:32 ч. UTC

Пазарно говорене

Gold Slips After Trump-Xi Call -- Market Talk

5.06.2025 г., 18:26 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5.06.2025 г., 18:06 ч. UTC

Пазарно говорене

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5.06.2025 г., 16:30 ч. UTC

Придобивния, сливания и поглъщания

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5.06.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

5.06.2025 г., 16:18 ч. UTC

Пазарно говорене

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5.06.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

5.06.2025 г., 16:12 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

5.06.2025 г., 16:12 ч. UTC

Пазарно говорене

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5.06.2025 г., 16:03 ч. UTC

Пазарно говорене

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5.06.2025 г., 15:49 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Sartorius Stedim Biotech. Прогноза

Ценова цел

By TipRanks

21.06% нагоре

12-месечна прогноза

Среден 234.67 EUR  21.06%

Висок 250 EUR

Нисък 210 EUR

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Sartorius Stedim Biotech. през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

9 ratings

5

Купи

4

Задържане

0

Продай

Техническа оценка

By Trading Central

202.7 / 211.7Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Strong Bullish Evidence

Настроение

By Acuity

14 / 538 Класиране в Финансови

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.